Shanghai Fosun Med-Tech Development Co., Ltd. of Shanghai at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers Trader OEM

Shanghai Fosun Med-Tech Development Co., Ltd.

No. 830 Chengyin Road, 200444 Shanghai
China
Telephone +86 21 60765888
Fax +86 21 60765999
shengli@fosunpharma.com

Hall map

MEDICA 2018 hall map (Hall 3): stand J26

Fairground map

MEDICA 2018 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.01  Glucose testing

Glucose testing

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.05  Other equipment for clinical chemistry

Other equipment for clinical chemistry

  • 03  Diagnostics
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.04  Other equipment for immunochemistry and immunology

Other equipment for immunochemistry and immunology

  • 03  Diagnostics
  • 03.04  Microbiology testing
  • 03.04.01  Bacteriology testing in microbiology

Bacteriology testing in microbiology

  • 03  Diagnostics
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.01  DNA testing

DNA testing

  • 03  Diagnostics
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.03  Polymerase chain reaction (PCR)

Polymerase chain reaction (PCR)

Our products

Product category: Glucose testing, Other equipment for clinical chemistry, Other equipment for immunochemistry and immunology, Bacteriology testing in microbiology, DNA testing, Polymerase chain reaction (PCR)

TBIL/DBIL

TBIL/DBIL---Vanadate oxidization method

Features

1. Dual liquid reagent

2. Providing OEM bulk package

3. No interference while the concentration of triglyceride ≤5mmol/L, ascorbic acid ≤0.5g/L and ferrohemoglobin ≤8.0g/L

4. Stable over 18 months from date of manufacture when stored at 2° C - 25° C.

Principle & Procedure

In the acid solution (PH3), bilirubin of specimen is oxidized into bilverdin by vanadate oxidization, at the meanwhile, the absorbance at 450nm cold be decline. Based on being measured the absorbance difference value of bilirubin oxidized before and after at 450nm, the bilirubin concentration could be determined in the specimen. End-point method

More Less

About us

Company details

Established in 1989, Shanghai Fosun Long March Medical Science Co., Ltd (herein after as Fosun Long March) is a high tech in-vitro diagnostics enterprise who is active in manufacturing, marketing and research and development of diagnostic and laboratory instrument and reagent. At the moment, Shanghai Fosun Long March Medical Science Co., Ltd is a wholly owned company by Shanghai Fosunpharma (Group), a China Fortune 500 company.

With product range from Clinical Chemistry kits, ELISA kits, Immunoturbidimetry kits , blood gas to electrolyte analyzer kits, we become one of the most influential brands in in-vitro diagnostics area. Our national wide sales network provides our customers products with good reputation. Being quick and efficient, our after-sales service network meets the demand of our customers whom spread throughout the country. Our products are manufactured under GMP and ISO13485 certification.

We have approximately 300 employees in the company. Fosun Long March has been rewarded with prizes by Ministry of Health, Shanghai Science and Technical Committee and Industry Associations. Also Fosun Long March has been recognized as "High-Tech Enterprise" by Shanghai Government.

As the investment platform of IVD division of FosunPharma Group, Fosun Long March has speeded up merger and acquisition in the centre of new product introduction. We directly hold Yaneng Biosciences (Shenzhen) Co., Ltd, Shanghai Fosun Med-Tech Development Co., Shanghai Biofosun Biotech Co., Ltd and Jiangsu Star Diagnostics Co.,Ltd. We partly hold SINNOWA Medical Science & Technology Co., LTD and Steellex Scientific Instrument Company. At the same time, we also have close cooperation with Saladax USA, Oxford Immunotec UK, and SDB Korea through FosunPharma.
Currently the company has obtained CFDA approval for a hundred products, and more than ten patents. The imported product T-spot TB, as only authorized tuberculosis diagnosis kits in China market, filled the gaps in this field for domestic market.

Fosun Long March strives to be the leading provider of in-vitro diagnostics solutions in China. We will continue our research and development, introduction of advanced technology and cooperation with research institute in future.

More Less